Qiang is Lead Biostatistician in Statistics Division at the George Institute and Conjoint Associate Professor at The University of New South Wales. He has a master degree in Biostatistics from the University of Sydney and a Bachelor degree in Public Health (Preventive Medicine) from Xi'an JiaoTong University (China). He is an accredited statistician by the Statistical Society of Australia since 2009. 

Prior to joining the George Institute in 2007, Qiang worked at the Woolcock institute of medical research (Australia) for one year and at the School of Public Health in Xi'an JiaoTong University (China) for six years. In his current position, Qiang Li is responsible for the design, analysis and reporting of numerous medical studies ranging from health surveys and epidemiological studies to multinational clinical trials in critical care, cardiovascular diseases, neurological and mental health illnesses, renal and metabolic diseases. In 19 years at the George Institute, he has worked on numerous major research studies including NHMRC funded studies as well as a number of clinical trials sponsored by the pharmaceutical industry.

Roy is a Global health researcher with a focus on Trauma outcomes and surgical healthcare systems in resource-poor settings. His academic, clinical and research career as the Professor & Chief of Surgical services at the Bhabha Atomic Research Centre (BARC) Hospital, HBNI University, Mumbai (an Universal Health Care scheme), spanned two decades.

On the health policy front, Roy has been the Technical Officer globally for Surgery & Anaesthesia in the Clinical Services & Systems unit at WHO Headquarters, Geneva; the Southeast Asia Regional Health Hub lead at Oxford Policy Management, the National Advisor; Public Health Planning and Evidence at NHSRC - Ministry of Health & Family Welfare (MoHFW) India; Director, State Health Systems Strengthening and Knowledge partnerships at CARE-India, Bihar.

Christine Jenkins is Program Head, Respiratory at The George Institute for Global Health; Professor of Respiratory Medicine at UNSW Sydney and Clinical Professor in the Concord Clinical School, University of Sydney.

Christine has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. Christine recently retired from clinical practice but continues to teach and supervise medical students and higher degree postgraduate students. She has had major roles in advocacy and leadership for lung health in Australia, most recently chairing Lung Foundation Australia, where she continues as a director, and previously chairing the National Asthma Campaign and the Federal Government’s National Asthma Advisory Group. She has participated in many government advisory groups and guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease.

Christine’s area of research interest is the clinical management of airways disease and patient-reported outcomes in response to therapeutic interventions, and she is currently implementing trials in asthma and COPD management and pulmonary rehabilitation in Australia and Asia. Her current work has also examined the role of telemedicine in specialist care during the pandemic and she is overseeing an ambitious study to develop a digital application for primary care to improve the diagnosis and evidence-based management of breathlessness.

In 2002 Christine was made a Member of the Order of Australia in recognition of services to respiratory medicine as a physician, administrator and educator, especially in the field of asthma education. In 2022, she was awarded the Governor General’s Medallion by His Excellency General the Honourable David Hurley AC DSC. This award recognises significant contributions to charities during the 2020 and 2021 pandemic years and is in recognition of Christine’s volunteer expertise, generosity, and exceptional leadership during the COVID-19 pandemic as Chair of Lung Foundation Australia.

Christine is a member and previous president of the Thoracic Society of Australia and New Zealand, and a member of the American Thoracic Society, European Respiratory Society and the Asia-Pacific Society of Respirology.

Professor Clare Arnott is Director of the Cardiovascular Program at The George Institute for Global Health and Associate Professor in Medicine at UNSW Sydney. 

Prof Arnott’s research focuses on women’s heart disease, heart failure, cardiovascular imaging, and cardio-kidney-metabolic (CKM) disease. Her work has significantly influenced national health policy and clinical management. 

As an experienced clinical trialist and the recipient of $28 million in research funding, Prof Arnott is an expert in investigating novel cardiometabolic treatments and pregnancy-related cardiovascular diseases including pre-eclampsia and pulmonary hypertension. 

She is also Pagent Director of Heart Lung Clinical Research at St Vincent's Hospital, Sydney, Director and Founder of the Women’s Heart Clinic at Royal Prince Alfred Hospital, and Senior Staff Specialist Cardiologist at St Vincent’s Hospital and Royal Prince Alfred Hospital, Sydney.

Prof Arnott is a Fellow of the Cardiac Society of Australia and New Zealand and the European Society of Cardiology, and member of the ANZACT Steering Committee, as well as serving on the editorial board of Heart, Lung and Circulation.